Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQWJ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,252
Award facts
- Contract value 100% obligated
- $87,251.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $87,251.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100 mg/4 ml vials of Keytruda, a branded oncology treatment. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is scheduled for ultimate completion by January 29, 2026, with performance occurring at the awardee's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, positions DMS Pharmaceutical Group as a regional prime vendor contractor through December 31, 2036. The company's established performance across numerous prior delivery orders for diverse specialty pharmaceuticals, biologics, and medical consumables demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQWJ8?
SPE2DR26FQWJ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQWJ8 worth?
The government has obligated $87,252 on SPE2DR26FQWJ8.
Is contract SPE2DR26FQWJ8 an order under another contract?
Yes. SPE2DR26FQWJ8 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWJ8 competed?
The extent of competition for SPE2DR26FQWJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award